U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C13H16ClNO
Molecular Weight 237.725
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of KETAMINE

SMILES

CNC1(CCCCC1=O)C2=CC=CC=C2Cl

InChI

InChIKey=YQEZLKZALYSWHR-UHFFFAOYSA-N
InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3

HIDE SMILES / InChI
Molecular Formula C13H16ClNO
Molecular Weight 237.725
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Sat Dec 16 17:02:39 UTC 2023
Edited
by admin
on Sat Dec 16 17:02:39 UTC 2023
Record UNII
690G0D6V8H
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
KETAMINE
HSDB   INN   MI   VANDF   WHO-DD  
INN  
Official Name English
NSC-70151
Code English
PMI-150
Code English
KETAFOL COMPONENT KETAMINE
Brand Name English
VETAKET
Brand Name English
CALYPSOL
Brand Name English
TEKAM
Brand Name English
CYCLOHEXANONE, 2-(2-CHLOROPHENYL)-2-(METHYLAMINO)-, (±)-
Systematic Name English
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Common Name English
(±)-KETAMINE
Common Name English
IMALGENE 1000
Brand Name English
KETASOL 100
Brand Name English
Special K
Common Name English
ANAKET V
Brand Name English
KETAMINE [VANDF]
Common Name English
NARKETAN
Brand Name English
CYCLOHEXANONE, 2-(2-CHLOROPHENYL)-2-(METHYLAMINO)-
Systematic Name English
KETAMINE [MI]
Common Name English
URSOTAMIN
Brand Name English
Ketamine [WHO-DD]
Common Name English
CLORKETAM 1000
Brand Name English
DL-KETAMINE
Common Name English
ketamine [INN]
Common Name English
KETAMINE [HSDB]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C245
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
CFR 21 CFR 522.1222A
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
NDF-RT N0000175681
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
FDA ORPHAN DRUG 829921
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
FDA ORPHAN DRUG 669318
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
FDA ORPHAN DRUG 812221
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
FDA ORPHAN DRUG 288809
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
WHO-VATC QN01AX03
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
WHO-ESSENTIAL MEDICINES LIST 1.1.2
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
FDA ORPHAN DRUG 883122
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
DEA NO. 7285
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
FDA ORPHAN DRUG 922622
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
NDF-RT N0000175975
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
WHO-ATC N01AX03
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
LIVERTOX NBK548337
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
FDA ORPHAN DRUG 840821
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
Code System Code Type Description
HSDB
2180
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
PRIMARY
INN
2156
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
PRIMARY
DRUG BANK
DB01221
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
PRIMARY
PUBCHEM
3821
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
PRIMARY
SMS_ID
100000082867
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
PRIMARY
EVMPD
SUB08365MIG
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
PRIMARY
DRUG CENTRAL
1523
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
PRIMARY
NSC
70151
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
PRIMARY
CAS
6740-88-1
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
PRIMARY
ChEMBL
CHEMBL742
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
PRIMARY
ECHA (EC/EINECS)
229-804-1
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
PRIMARY
CAS
33643-45-7
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
SUPERSEDED
CAS
100477-72-3
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
SUPERSEDED
IUPHAR
4233
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
PRIMARY
DAILYMED
690G0D6V8H
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
PRIMARY
RXCUI
6130
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
PRIMARY RxNorm
CHEBI
6121
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
PRIMARY
FDA UNII
690G0D6V8H
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
PRIMARY
CAS
79499-51-7
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
SUPERSEDED
NCI_THESAURUS
C61797
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
PRIMARY
MESH
D007649
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
PRIMARY
LACTMED
Ketamine
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
PRIMARY
EPA CompTox
DTXSID8023187
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
PRIMARY
MERCK INDEX
m6613
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
PRIMARY Merck Index
WIKIPEDIA
KETAMINE
Created by admin on Sat Dec 16 17:02:41 UTC 2023 , Edited by admin on Sat Dec 16 17:02:41 UTC 2023
PRIMARY
Related Record Type Details
Structure of KETAMINE, (R)-
ENANTIOMER -> RACEMATE
Structure of 1-[(2-Chlorophenyl)(methylimino)methyl]cyclopentan-1-ol
PRECURSOR->PARENT
PLASMA PROTEIN FRACTION (HUMAN)
BINDER->LIGAND
OCT-3
TRANSPORTER -> INHIBITOR
Structure of ESKETAMINE
ENANTIOMER -> RACEMATE
Structure of KETAMINE HYDROCHLORIDE
SALT/SOLVATE -> PARENT
OCT-1
TRANSPORTER -> INHIBITOR
NMDA RECEPTOR
TARGET -> INHIBITOR
Channel blocker
UNCOMPETITIVE
Ki
OCT-2
TRANSPORTER -> INHIBITOR
Related Record Type Details
Structure of HYDROXYNORKETAMINE, (2S,6S)-
METABOLITE ACTIVE -> PARENT
MAJOR METABOLITE IN PLASMA
Structure of NORKETAMINE, (R)-
METABOLITE LESS ACTIVE -> PARENT
NMDA receptor (rat brain) binding assay
IN-VITRO
Ki
Structure of DEHYDRONORKETAMINE, (R)-
METABOLITE LESS ACTIVE -> PARENT
Structure of NORKETAMINE, (S)-
METABOLITE ACTIVE -> PARENT
NMDA receptor (rat brain) binding assay
IN-VITRO
Ki
Structure of HYDROXYNORKETAMINE
METABOLITE -> PARENT
MINOR
Structure of Hydroxynorketamine (R,R;S,S)
METABOLITE ACTIVE -> PARENT
Structure of NORKETAMINE
METABOLITE ACTIVE -> PARENT
Structure of DEHYDRONORKETAMINE
METABOLITE ACTIVE -> PARENT
Structure of HYDROXYNORKETAMINE, (2R,6R)-
METABOLITE ACTIVE -> PARENT
MAJOR METABOLITE IN PLASMA MAY BE RESPONSIBLE ANTI-DEPRESSIVE ACTIVITY.
Structure of DEHYDRONORKETAMINE, (S)-
METABOLITE ACTIVE -> PARENT
Related Record Type Details
Structure of KETAMINE
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966